EDIT filings
Corporate insider profile
Linda Burkly Filing Activity
Latest reported as EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc. (EDIT).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$1,974.50
- Latest transaction
- Jun 3, 2026
Affiliated corporations
Reported company relationships
Transaction history